CASSANI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.199
AS - Asia 1.440
EU - Europa 1.035
SA - Sud America 220
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 66
OC - Oceania 2
Totale 5.041
Nazione #
US - Stati Uniti d'America 2.044
CN - Cina 447
SG - Singapore 422
IT - Italia 264
RU - Federazione Russa 191
HK - Hong Kong 188
VN - Vietnam 165
BR - Brasile 161
IE - Irlanda 151
DE - Germania 127
FR - Francia 73
CA - Canada 62
FI - Finlandia 59
BD - Bangladesh 57
GB - Regno Unito 55
ZA - Sudafrica 38
IN - India 36
MX - Messico 28
AR - Argentina 27
IQ - Iraq 16
CR - Costa Rica 15
JP - Giappone 15
PL - Polonia 14
NL - Olanda 12
UA - Ucraina 12
AT - Austria 11
ES - Italia 11
MA - Marocco 11
SE - Svezia 11
ID - Indonesia 9
IL - Israele 9
PH - Filippine 9
TR - Turchia 9
CL - Cile 8
MY - Malesia 8
CO - Colombia 7
JM - Giamaica 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
GP - Guadalupe 6
PK - Pakistan 6
PR - Porto Rico 6
PT - Portogallo 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
VE - Venezuela 6
EC - Ecuador 5
HN - Honduras 5
JO - Giordania 5
LT - Lituania 5
NI - Nicaragua 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
GT - Guatemala 4
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
LV - Lettonia 3
SV - El Salvador 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
TM - Turkmenistan 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
NG - Nigeria 1
NP - Nepal 1
Totale 4.959
Città #
San Jose 310
Singapore 219
Hong Kong 185
Ashburn 175
Dublin 150
Dallas 148
Council Bluffs 147
Chandler 124
Beijing 118
New York 79
Los Angeles 67
Ho Chi Minh City 62
Boardman 59
Lauterbourg 55
Munich 51
Redondo Beach 47
Milan 42
Nanjing 42
Shanghai 41
Johannesburg 36
Hanoi 35
Jacksonville 31
Santa Clara 31
Moscow 30
Princeton 23
Rome 23
Turku 23
Frankfurt am Main 22
Buffalo 21
Helsinki 21
Lawrence 21
Nanchang 21
Orem 19
Wilmington 19
Medford 18
Toronto 18
Montreal 17
Brooklyn 16
Columbus 16
Jiaxing 15
Nuremberg 15
Chicago 14
São Paulo 14
Warsaw 14
Atlanta 13
Boston 12
London 12
Naples 12
San Francisco 12
San José 12
Seattle 12
Changsha 11
Falkenstein 11
Mexico City 11
Shenyang 11
Tokyo 11
Haiphong 10
Mumbai 10
Pavia 10
Da Nang 9
Phoenix 9
Amsterdam 8
Bologna 8
Düsseldorf 8
Hebei 8
Turin 8
Manchester 7
Norwalk 7
Poplar 7
Stockholm 7
Tashkent 7
Washington 7
Brasília 6
Brussels 6
Chennai 6
Denver 6
Figino 6
Genoa 6
Houston 6
Rio de Janeiro 6
The Dalles 6
Brescia 5
Dhaka 5
Guangzhou 5
Hangzhou 5
Kingston 5
Kuala Lumpur 5
Managua 5
North Bergen 5
Palermo 5
Philadelphia 5
Piscataway 5
Quezon City 5
Tianjin 5
Vienna 5
Ankara 4
Ann Arbor 4
Austin 4
Baghdad 4
Catania 4
Totale 3.068
Nome #
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 155
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors? 120
Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies 116
Barbed suture in minimally invasive hysterectomy: a systematic review and meta-analysis 115
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis 113
Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women? 107
Sexuality in premature ovarian insufficiency 107
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 106
Bilateral ovarian malakoplakia: Case report and review of the literature with clinical and diagnostic considerations 104
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma 104
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 104
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause 103
Robotic single-site hysterectomy: Two institutions' preliminary experience 101
Different local estrogen therapies for a tailored approach to GSM 100
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 98
Robotic single-site surgery in management of obese patients with early-stage endometrial cancer 97
Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer 95
Robotic single-site technique allows pelvic lymphadenectomy in surgical staging of endometrial cancer 95
Robotic single site hysterectomy with bilateral salpingo-oophorectomy in female to male transsexualism. 94
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 93
Multiple human papillomavirus infection and high-grade cervical squamous intraepithelial lesions among women with human immunodeficiency virus: a systematic review and a meta-analysis 90
Current opinion on bevacizumab on endometrial cancer treatment 89
Single-site Versus Multiport Robotic Hysterectomy in Benign Gynecologic Diseases: A Retrospective Evaluation of Surgical Outcomes and Cost Analysis 89
The role of hormone therapy in urogenital health after menopause 89
Insights into the vulvar component of the genitourinary syndrome of menopause (GSM) 87
Oxaliplatin for the treatment of ovarian cancer 86
Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience 85
Veliparib for the treatment of ovarian cancer 81
Exploring differences in psychological aspects during pregnancy between cancer survivors and women without a history of cancer 79
Menopause and endometriosis 78
The role of fulvestrant in endometrial cancer 78
Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience 76
Robotic single-site surgery for female-to-male transsexuals: preliminary experience. 76
Oral contraception use in BRCA gene mutation carriers: information for counselling in routine clinical practice 73
Four pathogenic variants co-occurring in a MINAS early-onset breast cancer 72
Towards Inclusive Communication in Cancer Prevention and Treatment: A Case Study on Italian Informational Materials 69
Intralymphatic Histiocytosis Associated with Tubo-ovarian High-grade Serous Carcinoma: Case Report and Review of the Literature 69
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 69
Impact of totally implanted venous access port placement on body image in women with breast cancer 67
Discourses of Prevention: A Multimodal Study of HPV Vaccination Campaigns in Italy 66
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 66
The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis 65
Long-term risk of malignancy in the neovagina created using colon graft in vaginal agenesis-A case report 65
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms 65
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy 62
Intralesional hemorrhage in Krukenberg tumor: A case report and review of the literature 61
Surveillance alone in stage i malignant ovarian germ cell tumors: A MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 58
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 58
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 57
Psychological Well-Being, Prenatal Attachment, and Quality of Early Mother-Infant Interaction: A Pilot Study With a Sample of Mothers With or Without Cancer History 56
RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers 55
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): The MITO-9 study 50
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 50
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 50
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 49
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 49
Ovarian cancer onset across different BRCA mutation types: A view to a more tailored approach for BRCA mutated patients 46
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 45
Motherhood during or after breast cancer diagnosis: A qualitative study 45
Term pregnancy and mode of delivery 41
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 40
A meta-umbrella review of risk factors for vulvodynia: evidence from demographic, psychosocial, and biomedical domains 38
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project 38
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 37
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 36
Beyond the placebo effect: a systematic review and a network meta-analysis of treatment strategies for vulvodynia 16
Sexual health in women and sexual-gender-minority patients with cancer: A nationwide survey on healthcare professional awareness and attitude on behalf of MITO and AIRO-gynecology group 15
Sexual function after menopause: the role of vaginal estrogens 15
Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY) 13
null 5
Totale 5.041
Categoria #
all - tutte 22.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 0 0 0 0 1 5 1 6 7 1 14 53
2022/2023361 28 40 1 17 26 35 0 22 166 3 17 6
2023/2024285 7 38 7 13 10 60 7 16 2 9 16 100
2024/2025965 34 63 12 12 7 78 40 72 252 61 110 224
2025/20262.386 202 160 185 228 305 111 401 100 245 236 122 91
2026/2027706 46 142 113 250 155 0 0 0 0 0 0 0
Totale 5.041